Suppression of ATF4 via GPR68 inhibition further disrupts GBM survival, reinforcing its viability as a target for treatment.365,366 Additionally, epigenetic drug treatment of GSCs results in transposable element-derived transcripts that are selectively expressed in cancer cells, generating antigens with potential for targeted immunotherapy. The gene discussed is GPR68; the disease is glioblastoma.